Have a personal or library account? Click to login
Analysis of magnetic resonance contrast agent entrapment following reversible electroporation in vitro Cover

Analysis of magnetic resonance contrast agent entrapment following reversible electroporation in vitro

Open Access
|Sep 2024

References

  1. Kotnik T, Rems L, Tarek M, Miklavčič D. Membrane electroporation and electropermeabilization: Mechanisms and models. Annu Rev Biophys 2019; 48: 63–91. doi: 10.1146/annurev-biophys-052118-115451
  2. Batista Napotnik T, Polajžer T, Miklavčič D. Cell death due to electroporation – a review. Bioelectrochemistry 2021; 141: 107871. doi: 10.1016/j.bioelechem.2021.107871
  3. Aycock KN, Davalos RV. Irreversible electroporation: background, theory, and review of recent developments in clinical oncology. Bioelectricity. 2019; 1: 214–34. doi: 10.1089/bioe.2019.0029
  4. Yarmush ML, Golberg A, Serša G, Kotnik T, Miklavčič D. Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng 2014; 16: 295–320. doi: 10.1146/annurev-bioeng-071813-104622
  5. Verma A, Haines DE, Boersma LV, Sood N, Natale A, Marchlinski FE, et al. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation 2023; 147:1422–32. doi: 10.1161/CIRCULATIONAHA.123.063988
  6. Geboers B, Scheffer HJ, Graybill PM, Ruarus AH, Nieuwenhuizen S, Puijk RS, et al. High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy. Radiology 2020; 295: 254–72. doi: 10.1148/radiol.2020192190
  7. Čorović S, Mir LM, Miklavčič D. In vivo muscle electroporation threshold determination: Realistic numerical models and in vivo experiments. J Membrane Biol 2012; 245: 509–20. doi: 10.1007/s00232-012-9432-8
  8. Smerc R, Ramirez DA, Mahnic-Kalamiza S, Dermol-Cerne J, Sigg DC, Mattison LM, et al. A multiscale computational model of skeletal muscle electroporation validated using in situ porcine experiments. IEEE Trans Biomed Eng 2023; 70: 1–12. doi: 10.1109/TBME.2022.3229560
  9. Kos B, Mattison L, Ramirez D, Cindrič H, Sigg DC, Iaizzo PA, et al. Determination of lethal electric field threshold for pulsed field ablation in ex vivo perfused porcine and human hearts. Front Cardiovasc Med 2023; 10: 1160231. doi: 10.3389/fcvm.2023.1160231
  10. Cindric H, Mariappan P, Beyer L, Wiggermann P, Moche M, Miklavcic D, et al. Retrospective study for validation and improvement of numerical treatment planning of irreversible electroporation ablation for treatment of liver tumors. IEEE Trans Biomed Eng 2021; 68: 3513–24. doi: 10.1109/TBME.2021.3075772
  11. Pucihar G, Krmelj J, Reberšek M, Napotnik T, Miklavčič D. Equivalent pulse parameters for electroporation. IEEE Trans Biomed Eng 2011; 58: 3279–88. doi: 10.1109/TBME.2011.2167232
  12. Kotnik T, Frey W, Sack M, Haberl Meglič S, Peterka M, Miklavčič D. Electroporation-based applications in biotechnology. Trends Biotechnol 2015; 33: 480–8. doi: 10.1016/j.tibtech.2015.06.002
  13. Cemazar M, Jarm T, Miklavcic D, Macek Lebar A, Ihan A, Kopitar AN, et al. Effect of electric-field intensity on electropermeabilization and electro-sensitivity of various tumor-cell lines in vitro. Electro Magnetobiol 1998; 17: 263–2.
  14. Dermol-Černe J, Miklavčič D, Reberšek M, Mekuč P, Bardet SM, Burke R, et al. Plasma membrane depolarization and permeabilization due to electric pulses in cell lines of different ex-citability. Bioelectrochemistry 2018; 122: 103–14. doi: 10.1016/J.BIOELECHEM.2018.03.011
  15. Jacobs IV EJ, Campelo SN, Charlton A, Altreuter S, Davalos R V. Characterizing reversible, irreversible, and calcium electroporation to generate a burst-dependent dynamic conductivity curve. Bioelectrochemistry 2024; 155: 108580. doi: 10.1016/j.bioelechem.2023.108580
  16. Vižintin A, Vidmar J, Ščančar J, Miklavčič D. Effect of interphase and inter-pulse delay in high-frequency irreversible electroporation pulses on cell survival, membrane permeabilization and electrode material release. Bioelectrochemistry 2020; 134: 107523. doi: 10.1016/j.bioelechem.2020.107523
  17. Vižintin A, Marković S, Ščančar J, Miklavčič D. Electroporation with nanosecond pulses and bleomycin or cisplatin results in efficient cell kill and low metal release from electrodes. Bioelectrochemistry 2021; 140: 107798. doi: 10.1016/j.bioelechem.2021.107798
  18. Potočnik T, Sachdev S, Polajžer T, Maček Lebar A, Miklavčič D. Efficient gene transfection by electroporation—In vitro and in silico study of pulse parameters. Applied Sciences 2022; 12: 168237. doi: 10.3390/app12168237.
  19. Jordan ET, Collins M, Terefe J, Ugozzoli L, Rubio T. Optimizing electroporation conditions in primary and other difficult-to-transfect cells. J Biomol Tech 2008; 19: 328–34. PMID: 19183796
  20. Jiang C, Davalos R V., Bischof JC. A review of basic to clinical studies of irreversible electroporation herapy. IEEE Trans Biomed Eng 2015; 62: 4–20. doi: 10.1109/TBME.2014.2367543
  21. Pakhomov AG, Shevin R, White JA, Kolb JF, Pakhomova ON, Joshi RP, et al. Membrane permeabilization and cell damage by ultrashort electric field shocks. Arch Biochem Biophys 2007; 465: 109–18. doi: 10.1016/j.abb.2007.05.003
  22. Sengel JT, Wallace MI. Imaging the dynamics of individual electropores. Proc Natl Acad Sci U S A 2016; 113: 5281–6. doi: 10.1073/pnas.1517437113
  23. Napotnik TB, Miklavčič D. In vitro electroporation detection methods - an overview. Bioelectrochemistry 2017; 120: 166–82. doi: 10.1016/j.bioelechem.2017.12.005
  24. Miklavčič D, Beravs K, Šemrov D, Čemažar M, Demšar F, Serša G. The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 1998; 74: 2152–8. doi: 10.1016/S0006-3495(98)77924-X
  25. Ivorra A, Rubinsky B. Electric field modulation in tissue electroporation with electrolytic and non-electrolytic additives. Bioelectrochemistry 2007; 70: 551–60. doi: 10.1016/j.bioelechem.2007.02.001
  26. Miklavčič D, Šemrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 2000; 1523: 73–83. doi: 10.1016/S0304-4165(00)00101-X
  27. Boc N, Edhemovic I, Kos B, Music MM, Brecelj E, Trotovsek B, et al. Ultrasonographic changes in the liver tumors as indicators of adequate tumor coverage with electric field for effective electrochemotherapy. Radiol Oncol 2018; 52: 383–91. doi: 10.2478/raon-2018-0041
  28. Granata V, Fusco R, Setola SV, Palaia R, Albino V, Piccirillo M, et al. Diffusion kurtosis imaging and conventional diffusion weighted imaging to assess electrochemotherapy response in locally advanced pancreatic cancer. Radiol Oncol 2019; 53: 15–24. doi: 10.2478/raon-2019-0004
  29. Zmuc J, Gasljevic G, Sersa G, Edhemovic I, Boc N, Seliskar A, et al. Large liver blood vessels and bile ducts are not damaged by electrochemotherapy with bleomycin in pigs. Sci Rep 2019; 9: 3649. doi: 10.1038/s41598-019-40395-y
  30. Paturneau-Jouas M, Parzy E, Vidal G, Carlier PG, Wary C, Vilquin JT, et al. Electrotransfer at MR imaging: tool for optimization of gene transfer protocols-feasibility study in mice. Radiology 2003; 228: 768–75. doi: 10.1148/RADIOL.2283020482
  31. Kranjc M, Markelc B, Bajd F, Čemažar M, Serša I, Blagus T, et al. In situ monitoring of electric field distribution in mouse tumor during electroporation. Radiology 2015; 274: 115–23. doi: 10.1148/radiol.14140311
  32. Leroy-Willig A, Bureau MF, Scherman D, Carlier PG. In vivo NMR imaging evaluation of efficiency and toxicity of gene electrotransfer in rat muscle. Gene Ther 2005; 12: 1434–43. doi: 10.1038/sj.gt.3302541
  33. Scott LJ. Gadobutrol: a review in contrast-enhanced MRI and MRA. Clin Drug Investig 2018; 38: 773–84. doi: 10.1007/s40261-018-0674-9
  34. Čorović S, Županič A, Kranjc S, Al Sakere B, Leroy-Willig A, Mir LM, et al. The influence of skeletal muscle anisotropy on electroporation: in vivo study and numerical modeling. Med Biol Eng Comput 2010; 48: 637–48. doi: 10.1007/s11517-010-0614-1
  35. Peng W, Polajžer T, Yao C, Miklavčič D. Dynamics of cell death due to electroporation using different pulse parameters as revealed by different vi-ability assays. Ann Biomed Eng 2024; 52: 22–35. doi: 10.1007/s10439-023-03309-8
  36. Kandušer M, Šentjurc M, Miklavčič D. Cell membrane fluidity related to electroporation and resealing. Eur Biophys J 2006; 35: 196–204. doi: 10.1007/s00249-005-0021-y
  37. Neu WK, Neu JC. Mechanism of irreversible electroporation in cells: Insight from the models. In: Rubinsky B, editor. Irreversible electroporation. Series in biomedical engineering. Berlin, Heidelberg: Springer; 2010. p. 85–122.
  38. Avazzadeh S, O’Brien B, Coffey K, O’Halloran M, Keane D, Quinlan LR. Establishing irreversible electroporation electric field potential threshold in a suspension in vitro model for cardiac and neuronal cells. J Clin Med 2021; 10: 5443. doi: 10.3390/jcm10225443
  39. Saulis G. Pore disappearance in a cell after electroporation: theoretical simulation and comparison with experiments. Biophys J 1997; 73: 1299–309. doi: 10.1016/S0006-3495(97)78163-3
  40. Sözer EB, Pocetti CF, Vernier PT. Transport of charged small molecules after electropermeabilization — drift and diffusion. BMC Biophys 2018; 11: 4. doi: 10.1186/s13628-018-0044-2
  41. Polajžer T, Miklavčič D. Immunogenic cell death in electroporation-based therapies depends on pulse waveform characteristics. Vaccines 2023; 11: 1036. doi: 10.3390/vaccines11061036
  42. Kranjc M, Kranjc S, Bajd F, Serša G, Serša I, Miklavčič D. Predicting irreversible electroporation-induced tissue damage by means of magnetic resonance electrical impedance tomography. Sci Rep 2017; 7: 10323. doi: 10.1038/s41598-017-10846-5
  43. Kos B, Voigt P, Miklavcic D, Moche M. Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE). Radiol Oncol 2015; 49: 234–41. doi: 10.1515/raon-2015-0031
  44. Pavliha D, Kos B, Marčan M, Županič A, Serša G, Miklavčič D. Planning of electroporation-based treatments using web-based treatment-planning software. J Membr Biol 2013; 246: 833–42. doi: 10.1007/s00232-013-9567-2
  45. Crich SG, Biancone L, Cantaluppi V, Duò D, Esposito G, Russo S, et al. Improved route for the visualization of stem cells labeled with a Gd-/Eu-Chelate as dual (MRI and fluorescence) agent. Magn Reson Med 2004; 51: 938–44. doi: 10.1002/mrm.20072
DOI: https://doi.org/10.2478/raon-2024-0047 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 406 - 415
Submitted on: Jul 31, 2024
|
Accepted on: Aug 9, 2024
|
Published on: Sep 15, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Marko Strucic, Damijan Miklavcic, Zala Vidic, Maria Scuderi, Igor Sersa, Matej Kranjc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.